chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report has been received from a certified nurse practitioner concerning to a 63 year old female patient who was also a nurse with none pertinent medical history and none drug reactions/allergies. On 21-OCT-2013, the patient was vaccinated with ZOSTAVAX, 0.65 ml once, subcutaneous, (lot# not provided) at the hospital. Concomitant therapies included betablocker (unspecified), proton pump inhibitor (unspecified) and calcium channel blocker (unspecified). On 23-OCT-2013, within 2 days of receiving ZOSTAVAX the patient experienced internal tremors or shaking. The reporter stated that the patient never experienced anything like that before. No treatment was given for the adverse event. The patient sought medical attention by contacting office. At the time of reporting, the outcome of internal tremors or shaking was recovering (reported as the patient was 75 percent better). The reporter stated that the patient felt the adverse event was due to vaccine. Additional information has been requested.
past the 42 day mark for receiving the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (past the 42 day mark for receiving the 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (past the 42 day mark for receiving the 2nd dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (past the 42 day mark for receiving the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up information Received on 21-jun-2021 contains no new information.
Mild anaphylaxis--tongue swelling as well as occlusion of airway; This is a spontaneous report received from a non-contactable other healthcare professional. A 39-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot was unknown due to not available/provided to reporter at the time of report completion) via an unspecified route of administration on 19Mar2021 at age of 39-year-old at single dose for COVID-19 immunisation. Medical history included eczema, known allergies: Food sensitives including gluten and dairy. Rashes with prolonged skin contact with metals or adhesives. The patient's concomitant medications were not reported. No COVID prior vaccination. COVID was not tested post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient experienced mild anaphylaxis-tongue swelling as well as occlusion of airway on 19Mar2021. Started about 2min after shot. Occlusion lasted for 7minutes. EMS said vitals were normal. Swollen tongue lasted 24 hours. Have never had an allergic response to any vaccine before. The events were non-serious. No treatment was received for the events. The outcome of anaphylaxis was recovered in 2021, of tongue swelling was recovered on 20Mar2021, of occlusion of airway was recovered on 19Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event anaphylaxis cannot be totally excluded.
Not feeling well; Like flu; allergy; Runny itchy nose; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), INFLUENZA LIKE ILLNESS (Like flu), HYPERSENSITIVITY (allergy) and RHINORRHOEA (Runny itchy nose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling well), INFLUENZA LIKE ILLNESS (Like flu), HYPERSENSITIVITY (allergy) and RHINORRHOEA (Runny itchy nose). At the time of the report, MALAISE (Not feeling well), INFLUENZA LIKE ILLNESS (Like flu), HYPERSENSITIVITY (allergy) and RHINORRHOEA (Runny itchy nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Left facial and neck tingling and decreased sensation in face. Went to emergency department for ct scan and blood work and had an evaluation by a neurologist
Severity of symptoms: At their worst the symptoms were mild in the emergency department and the symptoms are unchanged. Pt is an employee here. Just received the Covid vaccine in the left arm. Shortly after vaccination she started to feel anxious with nausea. No vomiting, rash or swelling. No CP or SOB. Felt flushed without diaphoresis.
Had the vaccine on three different occasions and I still acquired the virus; Had the vaccine on three different occasions and I still acquired the virus; Felt like I was beaten about the back, chest; Rash on my back, neck and side of my face; Had the vaccine on three different occasions; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 3rd dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, feels awful, rash and extra dose administered. On an unknown date, the outcome of the vaccination failure, shingles, feels awful, rash and extra dose administered were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, feels awful and rash to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The patient was the reporter. The age at vaccination was not reported. The patient received shingles vaccine on three different occasions, which led to extra dose administered and experienced shingles, felt like beaten on chest, back and neck and rash on back, neck and side of face. The patient stated in his/her case shingles could not be prevented as he/she still acquired the virus. This case was considered as suspected vaccination failure as details regarding time to onset for target disease and laboratory confirmation were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
L arm swollen, warm. 5 cm long, 3 cm wide. BENADRYL otc.
Pt. received 2 vaccines @ approximately 9:20am. Had fainting episode @ 9:30am fell off exam table. Mother had 911 called- did not transport to ER. Did received bruise on rt. inner thigh. Left clinic with mother, alert, oriented and ambulatory. On 7-8-09, mother reported no lasting effects.
fatigue; right side of head headache that felt tender/ head tender; throat hurting; right side gland swelling; right side of neck pain; right shoulder soreness; sore right arm; achy muscles; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had history of Shingles). Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on an unknown date).   On 15th January 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 15th January 2021, less than a day after receiving Shingrix, the patient experienced fatigue, headache, throat pain, swollen glands, neck pain, shoulder soreness, pain in arm and muscle pain. On an unknown date, the outcome of the fatigue, headache, throat pain, swollen glands, neck pain, shoulder soreness, pain in arm and muscle pain were not recovered/not resolved.   It was unknown if the reporter considered the fatigue, headache, throat pain, swollen glands, neck pain, shoulder soreness, pain in arm and muscle pain to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient herself. The patient received 2nd dose of Shingrix in the right arm and in the same evening, the patient experienced achy muscles, a sore right arm, right shoulder soreness, right side of neck pain, right side gland swelling, throat hurting, right side of head headache that felt tender, and fatigue. Till the time of reporting, the adverse effects were not resolved. The reporter did not consent to followup.
Rash at injection site day after vaccination. On 3/16, rash on arms, shoulders, chest, stomach
3 days after receiving Moderna booster developed night sweats and enlarged 3 cm ,supraclavicular lymph node.Daily follow up visit x2 then follow up in 1 week.
Pt came into be evaluated because she received first covid vaccine at senior center. Pt was experiencing left subzygomatic cheek swelling (quarter sized area), denied difficulty  breathing, and denies ever having facial dermal fillers. Pt on low dose of prednisone, and took took Claritin D. Told to take OTC Benadryl
At 12:05pm employee with complaints of abdominal cramping (pain scale 7 or 8, with 10 being highest) and seeing occassional spots with peripheral vision; Temp 98.9. At 12:44 employee rates abdominal cramping at a 6, peripheral vision spots no longer present; compliants of being hot and cold.
04/07/21 within 10 minutes of getting vaccine felt strange all over and was light head and dizzy, stayed 30min reported and was allowed to leave. 04/07/21 afternoon severe diarrhea, 04/08 & 04/09 ran fever, chills, extreme joint and muscle aches, nausea, severe headache,  no energy, extremely sore injection site could not stand anything to touch, diarrhea,  04/10 to 04/14 arm severely sore, swollen, red, hot to touch and a knot at injection site and a 1" knot that ran down my arm to the elbow.  It was around the 15th or 16th of April before I could sleep on left side or stand anything to touch arm, and still had headache.   Concerned to get 2nd shot.  Took Xofran for the nausea, took tylenol, ibuprofen, excedrin for pain and headeache.  Considered going to the ER on 04/08/21.
Pt recvd the 1st dose of Engerix-B 9JAN92 & the next day pt exp a non-pruritic rash which was resolved;
ER visit on 12/25/2020 for tachycardia and SOB. She was to follow up with her PCP.
erythema on neck which spread to the trunk and the back/ urticaria lesions; This spontaneous report was received from a physician via a company representative, referring to a male patient of unknown age. The patient's concurrent conditions included environmental and food allergies. The patients pertinent medical history were unknown.   On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) intramuscularly, (dose, frequency, lot # and expiration date not mentioned) for vaccination. Concomitant therapies included diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (TDAP) and meningococcal acyw conj vaccine (crm197)(MENVEO).   On an unknown date after vaccination, the patient developed erythema on neck which spread to the trunk and the back. Subsequently, the physician diagnosed urticarial lesions. The patient received treatment with Benadryl and cetirizine hydrochloride (ZYRTEC)  for 1 day.   At the time of this report, the patient had recovered from urticaria. The casuality between vaccination with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) and urticaria was not reported.
blotchy, swollen, warm red rash near injection site on left shoulder appearing 14 days after vaccination and 4 days after having a painful, swollen lymph node in the left armpit. Started on Saturday as almost unremarkable and increased in size each successive day. I took a couple doses of Tylenol to no effect. Reported to my doctor's office on Monday the 19th with an updated picture on Wednesday the 21st and went to see my doctor. My doctor is concerned that what was a 2" in circumference red blotch now extended from my shoulder bone to 2" from my elbow.  Not being able to rule out cellulitis, she prescribed  cephalexin 500mg 4x daily.
Patient was administered a vaccine after refrigerator temperature dropped below desired range. Patient reported no adverse symptoms. On 1-5-15 when temps were discovered Merck was contacted and vaccine was determined to be stable. Case # 1-13179412640.
19 y.o. patient who was hospitalized with the diagnosis of vaccine related pericarditis/myocarditis after developing SOB and chest pain.  She is going to try to get more information on this patient, but she needs his consent. I will speak with patients father. In the interim, she is going to check with the hospital. In regards to the discharge summary, we will have to wait until the patient is discharged today, and it is translated. The reaction occurred about 3 days after receiving second dose.
Woke  up  10am, felt like I was getting bronchitis, some wheezing, walked outside to get mail and bring garbage can to back of my house. By the time I get inside, I had shortness of breath, lasted a few minutes and was gone, as fast as it started. Felt tired and some nausea for 2 days then fine.
Daily short lasting  shivers, chills that are persisting to date.  Also daily very short lasting sweating episodes
This spontaneous report as received from a nurse refers to a 14 year old patient of unknown gender. On 21-JUL-2014, the patient was vaccinated with a dose of PROQUAD injection, 0.5 ml, subcutaneous (lot#, expiration date, strength and indication not reported). Prior to receiving PROQUAD, the patient had received 2 doses of M-M-R II at unspecified times in the past and one dose of VARIVAX (Merck) in 2002. No adverse effect reported. It was unspecified if the patient sought medical attention. Additional information has been requested.
pt states today , april 27/2021 is the first day he has been able to get out of bed and dress for the day; symptoms started the morning after receiving shot which was april 14/2021, states body aches, chills and sweats (never took his temperature states he has not thermometer), no appetite but has been drinking, got up only to go to the bathroom; states he still feels lousy
PT. APPEARED TO BE ALRIGHT IMMEDIATELY FOLLOWING VACCINATION, BUT APPROXIMATELY 10 MIN. LATER SHE FAINTED.  APPROX. 1-2 MINUTES LATER SHE REGAINED CONCIOUSNESS.  SHE WAS HOT AND SWEATY AND ALSO THIRSTY.
Couldn't bear weight on his legs and was losing bowel and bladder control. He was paralyzed from the waist down over night.
This case was reported by a pharmacist and described the occurrence of apnea (infant) in a 3-month-old male subject who was vaccinated with PEDIARIX (GlaxoSmithKline). Concurrent medical conditions included prematurity. Concurrent medications included PRILOSEC, EES, Iron salt and Vitamin with iron and simethicone. On 2 July 2013 at 11:43 the subject received 1st dose of PEDIARIX (.5 ml, unknown route, left thigh). On 3 July 2013, 1 day after vaccination with PEDIARIX, the subject experienced apnea (infant), nodule injection site (described as large), bradycardia and decreased oxygen saturation. At the time of reporting, the premature infant was in the neonatal intensive care unit. The pharmacist reported that the subject experienced increased apnea and decreased oxygen saturation. The pharmacist reported that it was unknown if the immunization series was discontinued or delayed. The pharmacist considered the events were disabling and clinically significant (or requiring intervention). Relevant test results included apnea test with results of increased and oxygen saturation levels with result of decreased on 3 July 2013. The subject was treated with warm compress and oxygen. At the time of reporting the event of large injection site nodule was unresolved. The events of apnea (infant). bradycardia, and decreased oxygen saturation had improved. The pharmacist reported 4 other cases. See cases A1033994A, A1033995A, A1033996A, and A1033997A for details on the other cases.
On 05/16/2021 I was fatigue and I was having trouble breathing and it continued. On 05/21/2021 I went to an urgent care my heart rate was extremely high, I was in A-fib and they put me into an ambulance they took me to the hospital. I was admitted into the hospital. They diagnosed me with A-fib and tachycardia. I had never ever  had this before. I was on a lot of medications and  IVs, I had a cardio version where they shock your heart to get it back in rhythm. I was discharged on 05/24/2021, I came on amiodarone. I came home for a few days I was having rapid heart rate and difficulty breathing. then I was admitted another time to the Hospital and I was in 4 day. I came home on a medication called flecainide, In 2 days I was in congested heart failure and pulmonary edema.   I was admitted into the hospital again  into the Cardiac care unit. On June 14,2021 I came home.
Low grade fever, chills, headache, fatigue, joint pain, nausea, diarrhea, swelling in both sides of neck.
Fever 100.5, mild abdominal rash. No treatment. Fever lasted 1.5 days. Rash not yet resolved.
I almost die; I didn't build any response; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: UNKNOWN), via an unspecified route on unspecified date as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date, the patient experienced severe reaction to the Pfizer covid vaccine. Patient reported that immune compromised, didn't build any response and almost die on an unspecified date. The outcome of the events was unknown.  Information on Lot/Batch number has been requested.
This patient is a 6 month old female and was given the flu vaccine 0.5 ml instead of the 0.25 ml. Doctor examined patient and counseled mother. No adverse reactions occurred.
Severe hives.  Pt went to an Urgent Care and was prescribed diphenhydramine 25mg 1 to 2 po q6h prn.  Diphenhydramine was not helping with itching so pt went pt PC physician on 11/25 and was prescribed cimetidine 400mg bid x30 and prednisone 10mg 1 tid x7 days.
The patient was given the vaccine and within a few minutes stated that she felt like her throat was swelling.  She thought it might be a panic attack but after a few minutes she said it was getting worse.  She stated her throat was feeling more and more swollen, and she was getting more panicked due to this swelling. We called the paramedics and I gave her a dose of an epi pen.  The patient said there was some improvement.  The paramedics arrived and wanted to take her in to the hospital, she did not agree to leave with them but let them take her vitals and signed a  form stating she refused transport. She then drove herself to the hospital.  The patient then returned to the pharmacy stating that in ER they gave her ativan which helped to calm her down and she filled a prescription the ER dr gave her for prednisone and an epi pen
loss of smell; loss of taste; congestion; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (loss of smell), AGEUSIA (loss of taste), NASAL CONGESTION (congestion) and FATIGUE (fatigue) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ANOSMIA (loss of smell), AGEUSIA (loss of taste), NASAL CONGESTION (congestion) and FATIGUE (fatigue). At the time of the report, ANOSMIA (loss of smell), AGEUSIA (loss of taste), NASAL CONGESTION (congestion) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, SARS-CoV-2 test: negative (Negative) Patient tested negative twice.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medications were reported.
This spontaneous report was received from a healthcare worker and a nurse and it refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions and allergies were not reported. On 18-MAR-2015, the patient was vaccinated with expired dose of PROQUAD (Merck) (0.5 ml, subcutaneously, lot # reported as J009884, expiration date: 12-FEB-2015). No adverse effects were reported. Additional information has been requested.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history and current conditions were not provided. On 13-NOV-2015, the patient was vaccinated with an expired dose of GARDASIL lot # J003727 expiration date 07-NOV-2015. No adverse effect was reported. Additional information has been requested.
Swollen glands under armpit (temporary) lasted 6 hours.  Severe headaches, fever, night sweats, muscle soreness (lasted 24-48 hours). Erectile dysfunction, still suffering from this and haven?t had any relief in the over a year I?ve been post vaccine. I did not get the booster due to the issues and feeling like my heart isn?t working properly. Severe anxiety and feeling like my heart isn?t working right.
Expired vaccine used; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 30-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitants were reported. no treatment medications was provided
Right arm swollen, red, and hot to touch around area where VARICELLA was administered.  Pt states pain has worsened.  Advised pt to go to doctor to have checked.  Went to physician at Medical center and was prescribed KEFLEX for cellulitis.
She was doing everything on time when she was less than a month like sitting down on time, crawling, and talking and all of a sudden when she got her 1 year old shots she completely changed on me in like 3 days she started crying more and learning less and forgetting. It's really hard sometimes.
Immediate: fever, muscle aches,exhaustion. heart palpitations. Fever over 100 until for 2 months. Tachycardia over 120 most of the day, including nights.(Monitored by a fitness watch)  8 pound weigh loss
pt recv vax & p/approx 3hr swelling was noted;by early the next day a hard, reddened nodule measuring 16mm in diameter devel;was treated w/DPH & ice;